Community Investing Ideas

Global Weekly Picks

US$300
FV
7.5% undervalued intrinsic discount
15.62%
Revenue growth p.a.
10users have liked this narrative
4users have commented on this narrative
94users have followed this narrative
US$16.12
FV
25.4% undervalued intrinsic discount
1.15%
Revenue growth p.a.
5users have liked this narrative
2users have commented on this narrative
32users have followed this narrative
CA$49.9
FV
3.6% overvalued intrinsic discount
7.00%
Revenue growth p.a.
6users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
US$193.68
29.1% overvalued intrinsic discount
NateF Fair Value
Revenue growth
18.84% p.a.
Profit Margin
7.52%
Future PE
108.82x
Share price in 2029
US$283.75
US$49.35
4.0% undervalued intrinsic discount
NateF Fair Value
Revenue growth
31.29% p.a.
Profit Margin
8.09%
Future PE
14.87x
Share price in 2029
US$85.14
US$390.54
18.9% undervalued intrinsic discount
NateF Fair Value
Revenue growth
6.79% p.a.
Profit Margin
3.69%
Future PE
13.33x
Share price in 2029
US$546.7
€420
311.7% overvalued intrinsic discount
DenisH Fair Value
Revenue growth
1.38% p.a.
Profit Margin
8.02%
Future PE
32.35x
Share price in 2029
€516.61
SRTS logo
Sensus Healthcare

SRTS Market Outlook

Sensus Healthcare, Inc. (NASDAQ: SRTS) specializes in non-invasive treatments for skin conditions, notably through its Superficial Radiation Therapy (SRT) technology.Read more

View narrative
6users have liked this narrative
0users have commented on this narrative
43users have followed this narrative
US$13.42
74.1% undervalued intrinsic discount
NateF Fair Value
Revenue growth
20.39% p.a.
Profit Margin
22.54%
Future PE
12.76x
Share price in 2030
US$18.35
BIDU logo
Baidu

BIDU Market Outlook

Baidu Inc. (NASDAQ: BIDU) is a leading Chinese technology company specializing in internet-related services and artificial intelligence (AI).Read more

View narrative
2users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
US$74.22
68.4% overvalued intrinsic discount
NateF Fair Value
Revenue growth
5.25% p.a.
Profit Margin
15.27%
Future PE
10.53x
Share price in 2030
US$112.99
US$0.64
4.8% overvalued intrinsic discount
NateF Fair Value
Revenue growth
28.25% p.a.
Profit Margin
13.01%
Future PE
31.73x
Share price in 2030
US$5.26